Farmacogenética, Genética del Cáncer, Polimorfismos Genéticos y Farmacoepidemiología
Charité
Berlín, AlemaniaPublicaciones en colaboración con investigadores/as de Charité (9)
2017
-
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
Nature Genetics, Vol. 49, Núm. 5, pp. 680-691
2016
-
Genetic variants associated with antithyroid drug-induced agranulocytosis: A genome-wide association study in a European population
The Lancet Diabetes and Endocrinology, Vol. 4, Núm. 6, pp. 507-516
2014
-
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers
Breast Cancer Research, Vol. 16
-
DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
PLoS Genetics, Vol. 10, Núm. 4
2012
-
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Human Mutation, Vol. 33, Núm. 4, pp. 690-702
2011
-
Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2
Breast Cancer Research, Vol. 13, Núm. 6
-
Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers
Journal of the National Cancer Institute, Vol. 103, Núm. 2, pp. 105-116
-
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers
Human Genetics, Vol. 130, Núm. 5, pp. 685-699
2010
-
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Implications for risk prediction
Cancer Research, Vol. 70, Núm. 23, pp. 9742-9754